Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO®, the first allogeneic immunotherapy for patients with a rare cancer ...Middle East

CASTRES, France, June 21, 2024 /PRNewswire/ -- Pierre Fabre Laboratories has been awarded the "Prix Galien International" Prize in the "Best Product for a Rare/Orphan Disease" category for EBVALLO® (tabelecleucel), indicated as monotherapy for the treatment of patients with...

Hence then, the article about pierre fabre laboratories receives the galien international prize for ebvallo the first allogeneic immunotherapy for patients with a rare cancer was published today ( Friday 21/06/2024 - 02:09 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO®, the first allogeneic immunotherapy for patients with a rare cancer )

Also on site :

• Ghirardelli Recalls 13 Popular Products Over Possible Contamination
• From Taylor Swift-Approved Jewelry to Made-to-Order Songs: The Most Unique Mother’s Day Gift Ideas for 2026
• Record Store Day NYC 2026 Report: Early Lines Across Brooklyn & Queens, Swift & Grateful Dead Top Sellers